Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
N. Castro Unanua
Observed names:
N Castro Unanua,
N. Castro,
Natalia Castro,
Natalia Castro Unanua
Institutions:
Navarre Institute of Health Research,
Navarrabiomed,
Clinica Universidad de Navarra
Observed institutions:
Complejo Hospitalario de Navarra,
Navarre Institute of Health Research,
Navarrabiomed,
Clinica Universidad de Navarra
ORCID:
0000-0001-5484-0580
Observed ORCID:
0000-0001-5484-0580
OpenAlex ID:
A5027227089
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer
2023
·
Edouard Auclin
, Jose Benitez-Montanez
, et al.
·
Lung Cancer
·
37
Hyperprogressive Disease: Main Features and Key Controversies
2021
·
Hugo Arasanz
, Miren Zuazo
, et al.
·
International Journal of Molecular Sciences
·
35
PDF
Higher rate of pathologic complete response in patients with early-onset locally advanced rectal cancer
2024
·
J. Suarez
, M. Alsina
, et al.
·
ESMO Gastrointestinal Oncology
·
7
PDF
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
2020
·
Paula Jimenez-Fonseca
, Alberto Carmona-Bayonas
, et al.
·
Gastric Cancer
·
7
PDF
Lipid lowering treatment of severe hypertriglyceridemia with acute pancreatitis caused by everolimus in a patient with a neuroendocrine tumor
2020
·
J De Carlos Artajo
, N Castro Unanua
, et al.
·
Anales del Sistema Sanitario de Navarra
·
3
PDF
The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of Spain
2024
·
R. Vera
, N. Castro
, et al.
·
BMC Cancer
·
2
PDF
1408P Differences on immune biomarkers between KRAS G12C and KRAS non-G12C mutated non-small cell lung cancer
2023
·
L. Masfarre Pinto
, A.S.D.F.M. Parreira
, et al.
·
Annals of Oncology
·
2
PDF
Insights into ctDNA assessment to detect minimal residual disease (MRD) in localized colorectal cancer
2026
·
Ibone Labiano
, David Guerrero-Setas
, et al.
·
Scientific Reports
·
1
PDF
6P Circulating low-density neutrophils (LDNs) are associated with resistance to immunotherapy as frontline treatment for non-small cell lung cancer (NSCLC): Updated results and proteomic characterization
2024
·
N. Castro Unanua
, O. Fontecha
, et al.
·
Annals of Oncology
·
1
55P Differences in response to immune treatment between KRAS G12C and KRAS non-G12C mutated non-small cell lung cancer
2024
·
L. Masfarre Pinto
, A.S. De Freitas Matos-Parreira
, et al.
·
ESMO Open
·
1
3813P Circulating biomarkers and immune response in small cell lung cancer
2026
·
B. Agirre Mikelarena
, M. Artola
, et al.
·
Annals of Oncology
Clinical outcomes of KRAS G12C versus non-G12C mutant NSCLC treated with immunotherapy: a multicentre real-world study
2026
·
Laura Masfarré
, Ana Sofia Parreira
, et al.
·
Lung Cancer
PDF
Real-world Safety and Effectiveness of Neoadjuvant Chemoimmunotherapy in Squamous Cell Lung Cancer: A Retrospective European Multicenter Study
2026
·
Julio Herrero Colomina
, Ana Parreira
, et al.
·
Clinical Lung Cancer
Long-term survival and biomarkers of immunotherapy in small cell lung cancer: a systematic review
2026
·
Sandra Laguna
, Amaya Sádaba
, et al.
·
Translational Lung Cancer Research
306P Real-world outcomes and determinants of immune-mediated pneumonitis in stage III NSCLC treated with durvalumab after chemoradiotherapy
2026
·
A.M. Tortajada Lorca
, A. Vilalta
, et al.
·
ESMO Open
PDF
226P Safety and efficacy of neoadjuvant chemoimmunotherapy in squamous cell lung cancer: A retrospective European multicentre study
2026
·
J. Herrero Colomina
, A.S.D.F.M. Parreira
, et al.
·
ESMO Open
494P Preliminary data from the TEOGIC study: A comprehensive characterization of early-onset gastrointestinal cancer in Spain
2025
·
A.E. Huerta-Hernández
, I. Labiano
, et al.
·
Annals of Oncology
1479P Association between high baseline low density neutrophils and resistance to immunotherapy in untreated non-small cell lung cancer: Molecular characterization of low-density neutrophils
2023
·
H. Arasanz
, N. Castro Unanua
, et al.
·
Annals of Oncology
PDF
1410P Gastric cancer: Data from the AGAMENON-SEOM study
2021
·
I. Macias Declara
, L. Mihic
, et al.
·
Annals of Oncology
1394P Frequentist and Bayesian analysis of second line treatment effectiveness in AGAMENON-SEOM gastric cancer registry
2021
·
N. Martinez Lago
, A. Carmona-Bayonas
, et al.
·
Annals of Oncology
Show more works
View as search
Works count:
20
Citation count:
96
H-index:
4
I10-index:
2
Year
Topic
Type